The results of a new Taiwanese study into the little known role of circular RNA (circRNA) in colorectal cancer (CRC) pathogenesis suggest a new approach is needed to treatment of the cancer, in which therapy should not only target proteins, but also non-protein coding RNAs.
The results of a new Taiwanese study into the little known role of circular RNA (circRNA) in colorectal cancer (CRC) pathogenesis suggest a new approach is needed to treatment of the cancer, in which therapy should not only target proteins, but also non-protein coding RNAs.
Combining two monoclonal antibody (MAb) cancer therapies as one treatment not only shrank bulk tumors, but also targeted the cancer stem cells (CSCs) that can be responsible for disease relapse, according to a new Chinese study reported in the March 8, 2017, edition of Science Translational Medicine.
Novel analogues of a class of antibacterial compounds isolated from soil bacteria could lead to the development of urgently needed new treatments for tuberculosis (TB), according to the findings of a study led by Australian researchers at the University of Sydney.
Novel analogues of a class of antibacterial compounds isolated from soil bacteria could lead to the development of urgently needed new treatments for tuberculosis (TB), according to the findings of a study led by Australian researchers at the University of Sydney.
A study by Chinese researchers has identified a key suppressor of apoptosis in nonalcoholic steatohepatitis (NASH), and then showed that a small peptide segment derived from it ameliorated the currently untreatable liver disease in mice and nonhuman primates.
A specific immune system proteinase, granzyme A, was shown to promote arthritic inflammation in mice infected with chikungunya virus (CHIKV), in an Australian study reported in the Feb. 16, 2017, edition of PLOS Pathogens.
A study by Chinese researchers has identified a key suppressor of apoptosis in nonalcoholic steatohepatitis (NASH), and then showed that a small peptide segment derived from it ameliorated the currently untreatable liver disease in mice and nonhuman primates.
A specific immune system proteinase, granzyme A, was shown to promote arthritic inflammation in mice infected with chikungunya virus (CHIKV), in an Australian study reported in the Feb. 16, 2017, edition of PLOS Pathogens.
A nonvirulent tumor-targeting bacterial strain bioengineered to release multiple Toll-like receptor (TLR) ligands was shown to suppress tumor growth and prolong survival in mouse tumor models in a Korean study, suggesting it could be a new cancer immunotherapy in humans.
